Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China - Yang, Fan; Fu, Yu; Kumar, Arun; Chen, Mingsheng; Si, Lei; Rojanasarot, Sirikan (Annals of Translational Medicine; Vol 9, No 15 (August 13, 2021): Annals of Translational Medicine, 2021)